AtriCure

AtriCure

Senior Director, Product Marketing

Mason, OH; Minnetonka, MN · Director · Contract

Sponsorship not specifiedDetected 134 days ago
Product ManagementFDA RegulatoryMedical DevicesResearch

Stay score

odds of building a lasting career here

37Risky
Cap-exempt (no lottery)0
Sponsors this role80
Entry-level history0
PERM / green-card track0
Lottery odds40
Fits your clock70

Thin sponsorship signal and lottery-bound. A low-probability bet with your clock running. Prioritize cap-exempt roles and proven entry-level sponsors first.

Lottery odds assume a STEM candidate.

Personalize to your clock →

Community outcomes

No reports yet — be the first to help the next applicant.

About the role

  • The Senior Director, Product Marketing is responsible for owning and advancing the overall strategy, growth, and performance of the Pain Management portfolio.
  • The position serves as the primary voice and champion for Pain Management, shaping the long ‑ term vision while ensuring disciplined execution across multiple products, platforms, and stages of maturity.
  • Set the long ‑ term vision and growth strategy for Pain Management based on deep understanding of clinical practice, patient pathways, market dynamics, reimbursement, customer needs, and competitive landscape.

Responsibilities

  • Own and lead the overall product marketing and portfolio strategy for the Pain Management business, serving as the primary voice and champion for the therapy area across the organization.
  • Develop and manage portfolio ‑ level budgets and resourcing plans, ensuring efficient allocation of people and capital to support strategic priorities and financial commitments.

Skills

  • AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions.
  • Afib affects more than 33 million people worldwide.
  • AtriCure's Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib.
  • AtriCure's AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide.
  • AtriCure's Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients.
  • For more information, visit AtriCure.com or follow us on Twitter @AtriCure.

Company info

  • We offer supporting programs and resources that provide enriching and equitable opportunities for each person to contribute professionally and personally.

This listing is sourced directly from AtriCure's careers page and normalized into a canonical job model.